Skip to main content

Table 3 The frequency and intensity of HPV16 E7 single peptide-specific T cell response

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

HPV16 E7 peptide

Squamous cell carcinoma of cervix (n = 76)

Frequency (%)

Mean magnitude (SFC/106)

E7 Peptide-1 MHGDTPTLHEYMLDLQPE1-18

15.79

46.92

E7 Peptide-2 HEYMLDLQPETTDLYCYE9-26

11.84

39.78

E7 Peptide-3 PETTDLYCYEQLNDSSEE17-34

10.53

45.37

E7 Peptide-4 YEQLNDSSEEEDEIDGPA25-42

15.79

52.00

E7 Peptide-5 EEEDEIDGPAGQAEPDRA33-50

11.84

44.00

E7 Peptide-6 PAGQAEPDRAHYNIVTFC41-58

9.21

43.43

E7 Peptide-7 RAHYNIVTFCCKCDSTLR49-66

11.84

40.89

E7 Peptide-8 FCCKCDSTLRLCVQSTHV57-74

11.84

46.33

E7 Peptide-9 LRLCVQSTHVDIRTLEDL65-82

13.16

53.10

E7 Peptide-10 HVDIRTLEDLLMGTLGIV73-90

15.79

55.33

E7 Peptide-11 DLLMGTLGIVCPICSQKP81-98

15.79

46.83

  1. HPV, human papillomavirus